Myriad Genetics, Inc

Pharmaceuticals & Biotech

Myriad Genetics, Inc Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Myriad Genetics, Inc?

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individuals risk for developing disease later in life (predictive medicine), identify a patients likelihood of responding to a particular drug therapy (personalized medicine), assess a patients risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriads discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: “There is no more exciting story in medical science.” Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics. In August 2016 Myriad announced it would acquire Assurex Health for up to $410 million, expanding the companys genetic testing for psychotropic medicine selection. The global search for the genetic basis of breast and ovarian cancers began in earnest in 1988. In 1990, at an American Society of Human Genetics Meeting, a team of scientists led by Mary-Claire King, Ph.D., from University of California, Berkeley announced the localization through linkage analysis of a gene associated with increased risk for breast cancer (BRCA1) to the long arm of chromosome 17. In August 1994, Mark Skolnick and researchers at Myriad, along with colleagues at the University of Utah, the U.S National Institutes of Health (NIH), and McGill University sequenced BRCA1. In 2013, the actress Angelina Jolie had her ovaries removed because she tested positive for a mutation in the BRCA1 gene. This led to a surge in demand by women for genetic testing.

Highest paying job titles at Myriad Genetics, Inc include Sales Representative, Account Executive, and Medical Science Liaison

Snapshot

Employees2,600
Market Cap$1.8 billion
Revenue$851.1 million
5 Year Trend+1.8%
Net Income$4.6 million
NASDAQMYGN
Founded1991
Annual Report
Total value of jobs:
$31,815,000
Average Pay:
$108,214
Total Experts:
6
% Masters:
36%

Top Experts at Myriad Genetics, Inc

Myriad Genetics, Inc Salaries

Sales Representative

$90K

$125K

Average Salary:$91,373

Account Executive

$90K

$125K

Average Salary:$93,684

Medical Science Liaison

$90K

$90K

Average Salary:$90,000

Chief Healthcare Executive

$90K

$90K

Average Salary:$90,000

View All Salaries